Applied DNA Sciences, Inc. (APDN)

NASDAQ: APDN · IEX Real-Time Price · USD

0.440

-0.105 (-19.25%)

At close: Jul 2, 2024, 4:00 PM

0.457

+0.017 (3.79%)

After-hours: Jul 2, 2024, 7:58 PM EDT

Applied DNA Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Year	2023	2022	2021	2020	2019	2018 - 2007
Net Income	-9.95	-8.38	-14.29	-13.03	-8.93	Upgrade
Depreciation & Amortization	1.36	1.29	0.84	0.29	0.39	Upgrade
Share-Based Compensation	1.03	2.52	1.67	1	1.13	Upgrade
Other Operating Activities	1.33	-4.52	-1.61	0.6	0.24	Upgrade
Operating Cash Flow	-6.22	-8.98	-13.39	-11.14	-6.86	Upgrade
Capital Expenditures	-0.03	-0.49	-2.55	-1.06	-0.07	Upgrade
Acquisitions	-1.06	0	0	0	0	Upgrade
Investing Cash Flow	-1.1	-0.49	-2.55	-1.06	-0.07	Upgrade
Share Issuance / Repurchase	0	18.13	16.37	18.7	3.85	Upgrade
Debt Issued / Paid	0	0	-1.67	0.74	1.99	Upgrade
Other Financing Activities	-	-	-	-	-0.01	Upgrade
Financing Cash Flow	0	18.13	14.7	19.43	5.83	Upgrade
Net Cash Flow	-7.31	8.66	-1.23	7.23	-1.1	Upgrade
Free Cash Flow	-6.25	-9.47	-15.94	-12.21	-6.93	Upgrade
Free Cash Flow Margin	-46.76%	-52.10%	-176.53%	-631.98%	-128.58%	Upgrade
Free Cash Flow Per Share	-9.56	-21.11	-46.08	-62.29	-150.34	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).